
Several large studies have reported that long-term use of proton pump inhibitor (PPI) heartburn medications is associated with a higher risk of stomach cancer. Lawsuits now allege that the manufacturers of Prilosec, Nexium, and certain other PPIs knew or should have known about this risk and failed to warn patients and doctors.
This blog discusses specific PPI gastric cancer allegations, who may be eligible to file a claim, and the process for taking legal action. Individuals can learn more about the PPI stomach cancer lawsuit by contacting the attorneys at Wisner Baum.
Our firm represents people in stomach cancer lawsuits alleging the manufacturers of Prevacid, Protonix, Prilosec, Nexium, and other PPIs knew or should have known that long-term use of their medications could increase the risk of stomach cancer, but failed to warn patients or doctors. These product liability claims are pending in federal and state courts.
Allegations in stomach cancer claims include:
These allegations have not been proven in court as litigation is still pending. Individuals who want to learn more about the legal theory behind these claims are encouraged to read more about product liability cases.
Heartburn cancer lawsuits have centered on several widely used PPI drugs, including Nexium and Prilosec. Much of the research cited in these cases looks at PPIs as a class rather than at any single brand.
Proton pump inhibitors sold in the U.S. include:
Many people took generic or over-the-counter versions of these drugs. Whether a claim involving a generic or over-the-counter product can move forward depends on the product, who made it, and the law of the state involved, so these cases need attorney review. If you are unsure which medication you took, we recommend contacting a PPI attorney to find out whether you may be eligible.
Because each claim is unique, the best way to determine eligibility is to contact an attorney. Wisner Baum offers free and confidential case evaluations.
Qualifying factors for stomach cancer lawsuits may include:
Eligibility often depends on medical history, including how long they took a PPI and the type of stomach cancer they were diagnosed with. A free case review can help clarify whether a claim is possible.
All heartburn cancer lawsuits are subject to a filing deadline known as a statute of limitations. These deadlines are state-specific and usually begin to run from the date a person was diagnosed with a qualifying cancer or the date they could have reasonably connected their cancer to the prolonged use of a medication.
It is important to note that these deadlines are often far shorter than people expect. Once the deadline has passed, the claim is generally time-barred and cannot be filed.
In the past decade, several studies have raised concerns over a potential link between long-term use of proton pump inhibitors and an increased risk of stomach cancer. A 2018 study published in the journal Gut followed more than 63,000 adults in Hong Kong who had been treated for H. pylori. The researchers reported that long-term PPI use was associated with a higher risk of stomach cancer in this group, and that the association grew stronger the longer patients took the drugs.
More recently, a 2025 review in BMJ Open Gastroenterology reported that 20 of the 21 meta-analyses it examined found an association between PPI use and increased stomach cancer risk.
While findings like these point to broad patterns across large groups, they cannot be used to identify a cause for one person’s cancer. It is important to follow the guidance of a healthcare provider.
If you or someone in your family was diagnosed with stomach cancer after the long-term use of heartburn medication, you or your family member may be eligible to file a legal claim.
Steps to file a stomach cancer lawsuit:
If an attorney takes the case, the next step is filing a complaint in the appropriate court. During discovery, each side exchanges documents and evidence and takes testimony from witnesses and experts. If many similar cases are filed in federal court, they may be consolidated before one judge for pretrial proceedings. Depending on the facts of the case, claims may result in a settlement or proceed to trial for a decision. Each claim is different; no attorney can guarantee a particular outcome or timeline.
No. At this time, PPI stomach cancer claims are proceeding as individual lawsuits rather than as a class action.
In a class action, one or a few named plaintiffs represent a large group of people with similar claims, and class members who do not opt out are generally bound by the result.
Personal injury claims involving prescription drugs are rarely handled this way. Each person's medical history, the medication they took, how long they took it, and the type of cancer they developed can all differ. In an individual lawsuit, the plaintiff's own records and circumstances shape the case. The plaintiff, not a class representative, decides whether to accept any settlement offer.
Individuals who have been diagnosed with stomach cancer after taking PPI heartburn medications are encouraged to seek legal counsel. A free, confidential case review can help determine whether you may qualify for a legal claim.
Wisner Baum has extensive experience litigating complex cases against pharmaceutical companies. Since 1985, our firm has obtained billions of dollars in settlements and verdicts. Contact us today at (310) 207-3233 for a free and confidential case evaluation.